Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSCSNASDAQ:LFWDOTCMKTS:ORTIFNASDAQ:POAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeart Test Laboratories$3.92+6.2%$3.37$2.36▼$5.97$4.24M2.61120,627 shs67,739 shsLFWDReWalk Robotics$1.25+2.0%$1.41$1.18▼$4.77$13.76M0.25686,542 shs92,681 shsORTIFOrtho Regenerative Technologies$0.20$0.20$0.13▼$0.45$6.86M-1.163,282 shsN/APOAIPredictive Oncology$0.99+4.3%$1.07$0.55▼$3.06$8.85M1.31.93 million shs90,237 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeart Test Laboratories+1.91%-6.82%+1.91%+11.78%-32.91%LFWDReWalk Robotics-0.41%-2.78%-13.12%-27.08%-73.25%ORTIFOrtho Regenerative Technologies0.00%0.00%0.00%0.00%0.00%POAIPredictive Oncology+5.56%-2.67%-13.64%-26.36%-33.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSCSHeart Test Laboratories2.5537 of 5 stars3.53.00.00.02.70.01.3LFWDReWalk Robotics3.2327 of 5 stars3.55.00.00.03.30.01.3ORTIFOrtho Regenerative TechnologiesN/AN/AN/AN/AN/AN/AN/AN/APOAIPredictive Oncology2.6082 of 5 stars3.05.00.00.02.40.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSCSHeart Test Laboratories 3.00Buy$13.00231.63% UpsideLFWDReWalk Robotics 3.00Buy$9.00620.00% UpsideORTIFOrtho Regenerative Technologies 0.00N/AN/AN/APOAIPredictive Oncology 2.00Hold$3.00202.72% UpsideCurrent Analyst Ratings BreakdownLatest ORTIF, LFWD, POAI, and HSCS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025HSCSHeart Test LaboratoriesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.003/11/2025LFWDReWalk RoboticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.50 ➝ $4.003/11/2025LFWDReWalk RoboticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$13.00 ➝ $13.00(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSCSHeart Test Laboratories$14.70K288.27N/AN/A$11.16 per share0.35LFWDReWalk Robotics$25.41M0.54N/AN/A$5.42 per share0.23ORTIFOrtho Regenerative TechnologiesN/AN/AN/AN/A($0.16) per shareN/APOAIPredictive Oncology$1.73M5.12N/AN/A$2.04 per share0.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSCSHeart Test Laboratories-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%8/4/2025 (Estimated)LFWDReWalk Robotics-$22.13M-$3.04N/AN/AN/A-77.21%-43.02%-31.53%8/13/2025 (Estimated)ORTIFOrtho Regenerative Technologies-$3.93M-$0.11N/AN/AN/AN/AN/A-269.68%N/APOAIPredictive Oncology-$13.98M-$3.05N/AN/AN/A-1,012.32%-286.30%-122.11%8/12/2025 (Estimated)Latest ORTIF, LFWD, POAI, and HSCS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025LFWDReWalk Robotics-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million5/14/2025Q1 2025POAIPredictive Oncology-$0.09-$0.32-$0.23-$0.34$1.50 million$0.11 million3/13/2025Q3 2025HSCSHeart Test Laboratories-$2.53-$2.5722-$0.0422-$2.57N/AN/A3/7/2025Q4 2024LFWDReWalk Robotics-$0.20-$1.73-$1.53-$1.73$7.30 million$7.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSCSHeart Test LaboratoriesN/AN/AN/AN/AN/ALFWDReWalk RoboticsN/AN/AN/AN/AN/AORTIFOrtho Regenerative TechnologiesN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSCSHeart Test Laboratories0.011.721.52LFWDReWalk RoboticsN/A2.651.90ORTIFOrtho Regenerative TechnologiesN/A1.261.26POAIPredictive OncologyN/A1.201.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSCSHeart Test Laboratories17.24%LFWDReWalk Robotics26.76%ORTIFOrtho Regenerative TechnologiesN/APOAIPredictive Oncology9.04%Insider OwnershipCompanyInsider OwnershipHSCSHeart Test Laboratories1.80%LFWDReWalk Robotics2.50%ORTIFOrtho Regenerative TechnologiesN/APOAIPredictive Oncology3.44%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSCSHeart Test Laboratories101.08 million962,000Not OptionableLFWDReWalk Robotics6011.01 million10.36 millionOptionableORTIFOrtho Regenerative TechnologiesN/A34.96 millionN/ANot OptionablePOAIPredictive Oncology308.93 million6.44 millionNot OptionableORTIF, LFWD, POAI, and HSCS HeadlinesRecent News About These CompaniesPredictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average - Here's WhyMay 30, 2025 | americanbankingnews.comPredictive Oncology Inc.: Court Denies Renovaro Motion for an Expedited Trial in JulyMay 27, 2025 | finanznachrichten.deCourt Denies Renovaro Motion for an Expedited Trial in JulyMay 27, 2025 | globenewswire.comPredictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans BullishMay 23, 2025 | msn.comPredictive Oncology Inc. Advances AI-Driven Drug Discovery with Extensive Biobank of Tumor SamplesMay 22, 2025 | quiverquant.comAI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe AcquisitionMay 22, 2025 | globenewswire.comPredictive Oncology Expands AI-Driven Platform to Include Biomarker Discovery and Drug Repurposing for Precision OncologyMay 22, 2025 | nasdaq.comPredictive Oncology reports loss, but has "meaningfully expanded the potential" of its AI platformMay 20, 2025 | bizjournals.comPredictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"May 20, 2025 | globenewswire.comPredictive Oncology Inc. Reports Q1 2025 EarningsMay 17, 2025 | tipranks.comPredictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 15, 2025 | globenewswire.comPredictive Oncology develops new approach to identifying viable abandoned drugsApril 16, 2025 | markets.businessinsider.comRenovaro says Predictive Oncology terminated merger agreementApril 5, 2025 | markets.businessinsider.comPredictive Oncology Stock Price, Quotes and ForecastsApril 2, 2025 | benzinga.comPredictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate UpdateApril 1, 2025 | globenewswire.comPredictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer ResearchMarch 27, 2025 | insidermonkey.comPredictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer ResearchMarch 27, 2025 | msn.comTop 8 AI News Updates Driving Markets TodayMarch 25, 2025 | insidermonkey.comPredictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and OvaryMarch 25, 2025 | globenewswire.comPredictive Oncology completes sale of Skyline Medical assets to DeRoyalMarch 21, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeORTIF, LFWD, POAI, and HSCS Company DescriptionsHeart Test Laboratories NASDAQ:HSCS$3.92 +0.23 (+6.23%) Closing price 03:59 PM EasternExtended Trading$3.74 -0.18 (-4.59%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.ReWalk Robotics NASDAQ:LFWD$1.25 +0.03 (+2.04%) Closing price 04:00 PM EasternExtended Trading$1.25 0.00 (0.00%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.Ortho Regenerative Technologies OTCMKTS:ORTIF$0.20 0.00 (0.00%) As of 09/9/2022Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.Predictive Oncology NASDAQ:POAI$0.99 +0.04 (+4.32%) Closing price 04:00 PM EasternExtended Trading$1.00 +0.01 (+0.81%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
